Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Genix Pharmaceuticals ( (TSE:GENX) ) has provided an announcement.
Genix Pharmaceuticals has announced a non-brokered private placement to raise up to $100,000 through the sale of 2,000,000 units, each comprising one common share and one warrant. The funds will support the company’s Age Related Macular Degeneration Eyedrops project and general working capital. This move is expected to involve certain company insiders and requires regulatory approvals, highlighting the company’s strategic efforts to advance its product pipeline and strengthen its financial position.
More about Genix Pharmaceuticals
Genix Pharmaceuticals Corporation is a Canadian company specializing in ophthalmic drugs. It focuses on the research, development, manufacture, licensing, and sales of innovative prescription and over-the-counter ophthalmological products, catering to the growing needs of consumers worldwide, particularly aging baby boomers. The company has three products pending Health Canada approval.
Average Trading Volume: 21,307
Technical Sentiment Signal: Sell
Current Market Cap: C$2.07M
For detailed information about GENX stock, go to TipRanks’ Stock Analysis page.